Biological Surveying of Diverse Schiff Base Compounds: Antiproliferative, Antiradical and Enzyme Inhibition Activity

Paşa, Salih; Tuneg, Muhammed; Boğa, Mehmet

doi:10.1007/s11094-019-01997-y

Cited by 4 publications

(2 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Schiff bases offer distinctive qualities such as high synthesis flexibility and desirable biological characteristics. [22][23][24] Several studies have focused on Schiff base complexes of organotin (IV) with diverse ligands, highlighting the influence of ligand structure on the stability, reactivity, and biological activity of the resulting complexes. For instance, triorganotin (IV) complexes derived from amino acetate functionalized Schiff base ligands exhibit favorable anticancer activities against a range of human tumor cell lines, 25 similarly with novel triphenyltin (IV) 2-or 4-(arylimino) methyl)benzoates.…”

Section: Introductionmentioning

confidence: 99%

“…To further enhance the biological activities of organotin (IV) compounds, Schiff base functional groups have been incorporated into triorganotin (IV) carboxylates, leading to the synthesis of new organotin (IV) complexes with unique structures and favorable activities. Schiff bases offer distinctive qualities such as high synthesis flexibility and desirable biological characteristics 22–24 . Several studies have focused on Schiff base complexes of organotin (IV) with diverse ligands, highlighting the influence of ligand structure on the stability, reactivity, and biological activity of the resulting complexes.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Anthracene appended organotin (IV) compounds: Synthesis, structure elucidation and their cytotoxicity against A549 and RBL cancer cell lines

Paul,

Khan,

Shaik

et al. 2023

Applied Organom Chemis

View full text Add to dashboard Cite

Two new anthracene Schiff base triorganotin (IV) compounds trimethylstannyl(E)‐4‐((anthracen‐9‐ylmethylene)amino)benzoate (1) and triphenylstannyl(E)‐4‐((anthracen‐9‐ylmethylene)amino)benzoate (2) were synthesized by mixing trimethylstannyl (or triphenylstannyl) 4‐aminobenzoate and 9‐anthraldehyde in anhydrous toluene under refluxing conditions. Elemental analysis, FT‐IR, 1H‐NMR, 119Sn NMR and ESI‐MS were used to determine the composition of the compounds. X‐ray diffraction analyses revealed the structural details of the compounds. The in vitro cytotoxicity assessment of these compunds was screened against human A‐549 (lung carcinoma) and rat RBL (leukemia) cancer cell lines. Both compounds displayed a pronounced in vitro cytotoxic effect on the subjected cancer cell lines. Notably, the proliferation of A‐549 cells experienced substantial inhibition in the presence of compound 2. The mode of interaction with Hsp90 and NF‐κB p65 proteins responsible for cancer propagation was also assessed by molecular docking. Compounds 1 and 2 bind to the Hsp90 protein with binding energies of −307.65 and −373.45 kcal/mol, respectively, while to NF‐κB p65 protein the binding energies are of −329.35 and −395.35 kcal/mol, in the same order. Compound 2 exhibited a significantly high binding affinity to NF‐κB p65 and Hsp90 proteins validating our experimental findings from the in vitro experiments.

show abstract